4-((4-(Allyloxy)phenyl)sulfonyl)phenol, 95.0%, 250mg

{5-chloro-1H-imidazo[4,5-b]pyridin-2-yl}methanol, 95%, 250mg

(S)-4'-(2-Methylbutyl)-[1,1'-biphenyl]-4-carbonitrile, 97.0%, 10g

5-Bromo-4-chloro-2-(trifluoromethyl)pyridine, 97%, 2.5g

Methyl 3-formyl-1H-indole-5-carboxylate, 97.0%, 5g

Chrysoïdine G (CI 11270), pure, 50 g, emballage verre

7-(Trifluoromethyl)-1,2,3,4-tetrahydroquinoline, 95.0%, 5g

Ethyl 6-((tert-butoxycarbonyl)amino)spiro[3.3]heptane-2-carboxylate, 95.0%, 250mg

(1R)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE, 95.0%, 100mg

4-iodo-1,5-dimethyl-1H-pyrazole, 95.0%, 100mg

Swertiamarin>98.0%(HPLC)25mg

Methyl 2-bromo-5-cyanobenzoate, 95.0%, 5g

3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one, 95%, 250mg